A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma.
Elodie DurayMargaux LejeuneFrederic BaronYves BeguinNick DevoogdtAhmet KrasniqiYoline LauwersYong Juan ZhaoMatthias D'HuyvetterMireille DumoulinJo CaersPublished in: Journal of hematology & oncology (2021)
These results highlight the theranostic potential of radiolabelled anti-CD38 sdAbs for the monitoring and treatment of multiple myeloma.